Physician profile
Fred Stucky
NPI 1992751754
$11,663.61
in general payments reported to CMS, 2019-2025
30 companies · $394 in 2025
The $394 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,834 · 2020: $2,491 · 2021: $1,535 · 2022: $1,126 · 2023: $1,418 · 2024: $865 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,677.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $4,621.18 | 2019-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Silk Road Medical, INC. | $1,483.89 | 2019-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Medtronic, INC. | $1,391.83 | 2021-2025 | Hawkone, Endurant Iis, In.Pact Admiral |
| Musculoskeletal Transplant Foundation INC. | $1,317.09 | 2020 | |
| Cook Medical LLC | $718.22 | 2019-2023 | Zenith Spiral-Z |
| Medtronic Vascular, INC. | $676.21 | 2019-2020 | |
| Kerecis Limited | $232.70 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| W. L. Gore & Associates, INC. | $211.94 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Endoprosthesis |
| Lemaitre Vascular, INC. | $203.95 | 2019-2023 | Artegraft Vascular Graft |
| Inari Medical, INC. | $111.98 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $106.14 | 2021-2023 | Xarelto |
| Smith+Nephew, INC. | $99.09 | 2022-2025 | Oasis, Grafix, Grafix Pl |
| Penumbra, INC. | $79.13 | 2024 | Indigo System |
| E.R. Squibb & Sons, L.L.C. | $69.43 | 2021-2024 | Eliquis |
| Bard Peripheral Vascular, INC. | $51.46 | 2023-2025 | Crosser Iq, Venclose Maven Catheter |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $37.53 | 2025 | |
| Medela LLC | $31.23 | 2023 | Invia Motion Endure |
| Baxter Healthcare | $30.10 | 2022-2024 | Preveleak |
| Organogenesis INC. | $29.15 | 2019 | |
| Abbott Laboratories | $24.11 | 2022 | |
| Pfizer INC. | $16.92 | 2022 | |
| Polynovo North America LLC | $16.72 | 2023 | |
| Convatec INC. | $16.35 | 2021 | |
| Acell, INC. | $14.65 | 2019 | |
| Tactile Systems Technology INC | $13.03 | 2019 | |
| Cook Incorporated | $12.54 | 2021 | |
| Terumo Medical Corporation | $12.52 | 2019 | |
| Ekos Corporation | $12.12 | 2019 | |
| Boston Scientific Corporation | $11.32 | 2020 | |
| Angiodynamics, INC. | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fred Stucky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.